● Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Condition: mCRPC (Metastatic Castration-resistant Prostate Cancer) · Prostate Cancer · Sponsor: Pathos AI, Inc.

PhasePhase 1/Phase 2

Planned participants120

Who can joinMale, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a dose-finding study to assess the safety and preliminary antitumor activity of Pocenbrodib alone or with darolutamide in patients with metastatic castration-resistant prostate cancer (mCRPC)

This description comes directly from the study's public registry record.

Talk to the study team

Steve Kye, MD, MPH · 708-232-3791 · clinicaltrials@pathos.com

Always discuss trial participation with your own doctor first.

Locations (18)

MemorialCare Orange Coast Medical Center	Fountain Valley, California, United States	Recruiting
Cancer and Blood Research Center	Los Alamitos, California, United States	Recruiting
University of Colorado Health	Aurora, Colorado, United States	Recruiting
Mount Sinai Medical Center	Miami, Florida, United States	Recruiting
Emory University Hospital	Atlanta, Georgia, United States	Recruiting
University of Chicago	Chicago, Illinois, United States	Recruiting
Community Health Network	Indianapolis, Indiana, United States	Recruiting
Ochsner	Jefferson, Louisiana, United States	Recruiting
Johns Hopkins Hospital	Baltimore, Maryland, United States	Recruiting
Karmanos Cancer Institute	Detroit, Michigan, United States	Recruiting
Siteman Cancer Center	St Louis, Missouri, United States	Recruiting
Nebraska Cancer Specialists	Omaha, Nebraska, United States	Recruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06785636